# Octapharma Plasma, Inc. – FDA Inspection, Jan 23, 2012

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/51306422-e752-4a64-a67d-040090123afd
Source feed: FDA_Inspections

> FDA inspection 766276 of Octapharma Plasma, Inc., January 23, 2012. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR parts 600 and 606. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 766276
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2012-01-23
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1059959 - 2018-05-11
- [FDA Inspection 887635 - 2014-06-30](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/bacbf162-10ef-4032-8aca-926b7e4c99ff)
- FDA Inspection 796542 - 2012-07-11

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/5309845a-1ad0-49fc-83b9-17e51cddabd0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
